Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04287010 · ClinicalTrials.gov registry record
Potassium Flux in Hemodialysis Patients
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 25
- Enrollment target
NCT04287010: Completed study, sponsored by Washington University School of Medicine.
NCT04287010 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04287010 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Current practice of outpatient hemodialysis entails prescription of standard electrolyte concentrations based upon patient prescription history and monthly serum electrolyte measurements. Dialysate concentration of potassium can be adjusted based on standard available concentrations including 2mmol/L and 3mmol/L. Standard available dialysate concentration of Magnesium is 0.5mmol/L (which is not ordinarily adjusted further). Potassium and Magnesium are not routinely measured before or after each dialysis, therefore serum levels are largely unknown outside of once monthly measurements. This study aims to further study this correlation of electrolyte fluctuations (potassium and magnesium) and cardiac arrhythmias/heart rate variability in the ESRD population.
Primary Outcome
This study aims to assess if there is a correlation between serum electrolyte changes and abnormal heart rhythms or heart rate variability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-05-21 |
| Est. Completion | 2020-11-30 |
What the finished NCT04287010 record still lists
NCT04287010 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04287010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04287010 about?
NCT04287010 is a clinical study titled "Potassium Flux in Hemodialysis Patients". Current practice of outpatient hemodialysis entails prescription of standard electrolyte concentrations based upon patient prescription history and monthly serum electrolyte measurements. Dialysate concentration of potassium can be adjusted based on standard available concentrations including 2mmol/...
What is the current status of trial NCT04287010?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2019-05-21. Estimated completion is 2020-11-30.
Who is sponsoring clinical trial NCT04287010?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI